Robert DeMichiei - 05 Jun 2026 Form 4 Insider Report for Ardent Health, Inc. (ARDT)

Reporting relationship: Director
Issuer ticker: ARDT
Reported as of: 05 Jun 2026
Net transaction value: +$98,300
SEC form: 4
Accepted by SEC: 08 Jun 2026, 12:50:38 UTC
Prior SEC filing: 03 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Stephen C. Petrovich, Attorney-in-Fact

Key filing fact

Robert DeMichiei filed Form 4 for Ardent Health, Inc. (ARDT) on 08 Jun 2026.

Key facts

This page summarizes Robert DeMichiei's Form 4 filing for Ardent Health, Inc. (ARDT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 08 Jun 2026, 12:50.

Change

Previous filing in this sequence was filed on 03 Jun 2026.
Current net transaction value: +$98,300.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001928634 Primary reporting owner

DeMichiei Robert

Relationship: Director
Address: 340 SEVEN SPRINGS WAY, SUITE 100, BRENTWOOD
Signature: /s/ Stephen C. Petrovich, Attorney-in-Fact
Signature date: 08 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ARDT transaction

Common Stock

Purchase

Transaction value: $98,300
Shares: +11,260
Change %: +46%
Price: $8.73
Shares after: 35,564
Date: 05 Jun 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price reported in Column 4 is a weighted average price of $8.73 per share. These shares were purchased in multiple transactions on 06/05/26 at prices ranging from $8.60 to $8.78, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.